Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02950285 · ClinicalTrials.gov registry record · NA
Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 2,336
- Enrollment target
NCT02950285: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02950285 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 2,336 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02950285, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,336 participants
- Enrollment target
Study Summary
The overall goal is to improve outcomes among patients with atrial fibrillation (AF) by preventing stroke. The investigators propose to implement an automated algorithm using electronic medical record (EMR) data to alert physicians in a large primary care practice network at the Massachusetts General Hospital (MGH) of their patients with AF and elevated stroke risk that are not taking an anticoagulant for stroke prevention. The investigators hypothesize that interventions to notify physicians of such individuals may prompt reassessment for the need for anticoagulation, and thereby increase guideline-indicated anticoagulation rates. Additionally, in a survey component, physicians will characterize reasons for not pursuing anticoagulation in AF patients at elevated risk for stroke.
Primary Outcome
Difference in the proportion of patients with AF at high risk of stroke taking an anticoagulant at 3-months in the baseline alert arm , compared to the proportion taking an anticoagulant at 3-months in the 3-month alert arm
Interventions
- OTHER Baseline alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,336 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2017-05-07 |
| Phase | NA |
What the finished NCT02950285 record still lists
NCT02950285 is an interventional study that assigns participants to a tested intervention. Its 2,336 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (66% higher).
The record links to 0 conditions, and to 1 intervention - of which Baseline alert is the first listed.
NCT02950285 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02950285 about?
NCT02950285 is a clinical study titled "Automated Physician Notifications to Improve Guideline-Based Anticoagulation in Atrial Fibrillation". The overall goal is to improve outcomes among patients with atrial fibrillation (AF) by preventing stroke. The investigators propose to implement an automated algorithm using electronic medical record (EMR) data to alert physicians in a large primary care practice network at the Massachusetts Genera...
What is the current status of trial NCT02950285?
This trial is currently completed. It is a NA study. The enrollment target is 2,336 participants. The study started on 2017-02-07. Estimated completion is 2017-05-07.
What interventions are being tested in trial NCT02950285?
The interventions under investigation include: Baseline alert (OTHER).
Who is sponsoring clinical trial NCT02950285?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02950285's enrollment target sits among peer trials
2,336 46th of 2000 higher than 1,955 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06679140 · 2,330 participants · Phase 3
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- NCT03099850 · 2,345 participants
Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies
- NCT00025935 · 2,350 participants
Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
- NCT05700760 · 2,320 participants · NA
The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI